Abingdon Health PLC to Announce Interim Results and Host Investor Presentation

Abingdon Health PLC ( (GB:ABDX) ) just unveiled an announcement.

Abingdon Health PLC announced it will release its unaudited interim results for the six months ending December 31, 2024, on March 24, 2025. The company will host a live investor presentation on March 26, 2025, open to existing and potential shareholders. This announcement underscores Abingdon Health’s commitment to transparency and engagement with its stakeholders, potentially impacting its market positioning by enhancing investor relations and confidence.

More about Abingdon Health PLC

Abingdon Health PLC is a leading med-tech contract service provider with an international customer base. The company specializes in lateral flow product development, regulatory support, technology transfer, and manufacturing services for various sectors, including infectious disease, clinical testing, animal health, and environmental testing. Abingdon Health also offers regulatory services through Compliance Solutions and IVDeology, supporting the in vitro diagnostic and medical device industries. Additionally, the company provides self-tests through its Abingdon Simply Test e-commerce platform, offering consumers tools to manage their health and wellbeing.

YTD Price Performance: -12.90%

Average Trading Volume: 116,209

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £13.07M

For an in-depth examination of ABDX stock, go to TipRanks’ Stock Analysis page.